Levetiracetam Aurobindo

Levetiracetam, the active ingredient in Levetiracetam Aurobindo, is an anticonvulsant presented as a tablet for oral use. It is indicated for the control of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients diagnosed with epilepsy, and is marketed across the European Union.

GNH USA supplies Levetiracetam Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for generic antiepileptic medicines. The company adheres to stringent quality standards and offers global logistics support.

Levetiracetam is an antiepileptic agent used to manage seizure disorders.

Partial seizures: reduces the frequency of focal onset seizures. Generalized tonic‑clonic seizures: helps achieve seizure control in primary generalized seizures. Myoclonic seizures: decreases occurrence of myoclonic jerks in appropriate patients.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate cranial pain. - Irritability: increased agitation or mood swings.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or Stevens‑Johnson syndrome. - Mood changes: depression, suicidal thoughts, or aggressive behavior. - Hematologic abnormalities: neutropenia or thrombocytopenia.

Before initiating therapy, clinicians should consider several safety aspects.

Renal impairment: dose may need adjustment in patients with reduced kidney function. Pregnancy: category B, use only if benefit outweighs risk. Psychiatric symptoms: monitor for mood changes, depression, or aggression. Concomitant CNS depressants: may enhance sedation. Drug interactions: review concomitant medications for potential interactions. Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations, decreasing efficacy. - Phenobarbital: may lower levetiracetam levels and compromise seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase risk of central nervous system adverse effects. - Alcohol: can potentiate sedation and dizziness. - Other antiepileptics (e.g., phenytoin): monitor seizure control and adjust therapy as needed.